Akso Health Group / Fundamentals

    Income statement

    Net revenue
    €2.07M
    Cost of goods sold
    €1.97M
    Gross profit
    €104.79K
    SG&A expenses
    €7.52M
    R&D expenses
    €0.00
    EBITDA
    €0.00
    D&A
    €7.41M
    EBIT
    -€7.41M
    Interest expenses
    €0.00
    EBT
    -€7.80M
    Tax expenses
    €21.44K
    Net income
    -€7.78M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €7.82M
    Changes in working capital
    €1.45M
    Operating cash flow
    €1.16M
    Capex
    €0.00
    Other investing cash flow
    €1.31M
    Net investing cash flow
    -€46.95M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €120.18M
    Debt repayment
    €0.00
    Other financing cash flow
    €112.96M
    Net financing cash flow
    €112.96M
    Foreign exchange effects
    -€1.09M
    Net change in cash
    €99.32M
    Cash at end of period
    €73.08M
    Free cash flow
    €1.16M

    Balance sheet

    Cash and cash equivalents
    €73.08M
    Cash and short-term investments
    €73.08M
    Total receivables
    €0.00
    Inventory
    €164.05K
    Other current assets
    €345.69K
    Total current assets
    €121.85M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €121.85M
    Accounts payable
    €0.00
    Short-term debt
    €0.00
    Other current liabilities
    €2.66M
    Total current liabilities
    €3.08M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    -€356.09K
    Total non-current liabilities
    €356.09K
    Total liabilities
    €3.08M
    Common stock
    €37.61K
    Retained earnings
    -€54.85M
    Other equity
    -€3.51M
    Total equity
    €118.77M
    Total liabilities and shareholders' equity
    €121.85M

    Company information

    Market capitalization
    €45.52M
    Employees
    9
    Enterprise Value
    -€54.87M

    Company ratios

    Gross margin
    5.1% Much worse than peer group: 80.5%
    EBITDA margin
    0.0%
    EBIT margin
    -357.8% Much worse than peer group: -15.8%
    EBT margin
    -376.6% Much worse than peer group: -20.4%
    Net margin
    -375.3% Much worse than peer group: 11.0%
    ROE
    -6.5% Worse than peer group: 12.5%
    ROA
    -6.4% Worse than peer group: 3.5%
    Asset turnover
    1.7% Worse than peer group: 7.5%
    FCF margin
    56.0% Much worse than peer group: 796.8%
    FCF yield
    2.5%
    Efficiency ratio
    100.0%
    Net sales per employee
    €230.17K
    Net income per employee
    -€863.93K

    Notifications